Biosimilar Clinical Development
Aug 7, 2023 11:31:22 AM
225 W. Station Square Drive Suite 200,
Pittsburgh, Pennsylvania,
United States 15219
4123633300
Novum’s experienced global team of scientists, physicians, and respected CRO industry professionals will collaborate with your team to develop a pathway for your biosimilar clinical product development programs.
Biosimilars are Becoming a Key Sector of the Global Pharmaceutical Market
88.5% of prescriptions filled are for unbranded generic drugs
Biosimilars are gaining traction and will continue to grow in market share
Since 2006:
US – 35 biosimilars approved by FDA
EU – 55 biosimilars approved by EMA